Clinical Trial Update: Specimens for Septin 9 Performance [EARLY_Phase 1]

View source ↗

Summary

A completed EARLY Phase 1 trial update describing specimens used to assess SEPT9 DNA methylation performance for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Epi proColon (Septin 9 DNA methylation test) (Septin 9 DNA methylation test)

Snippet

Sponsor: Epigenomics, Inc | Conditions: Colorectal Cancer | EARLY_Phase 1 | Status: COMPLETED